A shareholder filed a lawsuit against Intel on March 5, 2026, which was unsealed on March 11 and became public on March 12. The suit alleges that Intel’s 10 % equity stake in the U.S. government, created under the CHIPS Act, was improperly obtained and violates corporate governance rules.
The 10 % stake was funded by converting $2.2 billion in CHIPS Act grants and $8.9 billion in federal grants that had been awarded but not yet paid, valuing the stake at roughly $11 billion. The deal was reportedly made to secure the funding and avoid “extortionary threats” from the Trump administration, according to the lawsuit’s allegations.
The defendants named in the suit include Intel, the U.S. Department of Commerce, Commerce Secretary Howard Lutnick, former board chair Frank Yeary (who retired in March 2026), and CEO Lip‑Bu Tan. The plaintiffs claim the board breached fiduciary duties by approving the stake under duress and that the contract is unlawful.
Intel’s Q4 2025 earnings, released January 22, 2026, showed revenue of $13.7 billion, down 4 % year‑over‑year, and a non‑GAAP EPS of $0.15, beating analyst expectations of $0.08. The company forecast a Q1 2026 GAAP loss of $(0.21) and a non‑GAAP EPS of $0.00, with revenue projected between $11.7 billion and $12.7 billion—below expectations. These figures illustrate a mixed performance backdrop for the lawsuit.
Segment data from the Q4 2025 report reveal that the Data Center and AI segment grew 9 % year‑over‑year to $4.7 billion, while the Client Computing (PC) segment revenue fell 7 % to $8.2 billion. The foundry business recorded approximately $10.3 billion in losses for fiscal 2025, underscoring margin pressure in core operations.
Management commentary provides context for the stake. In August 2025, CFO David Zinsner said that selling stock to the Trump administration removed uncertainty about receiving CHIPS Act funds. CEO Lip‑Bu Tan has expressed confidence in Intel’s transformation strategy, but the lawsuit introduces new uncertainty about governance and the legality of the stake.
Analysts have issued mixed guidance following the lawsuit. While some maintain a “Hold” or “Reduce” stance, price targets range from $45 to $51, reflecting caution amid potential regulatory scrutiny and reputational risk.
The lawsuit could trigger regulatory investigations, penalties, and reputational damage, and it may affect Intel’s capital structure and investor confidence. The 10 % stake, valued at $11 billion, represents a significant portion of Intel’s equity and could have material implications for the company’s governance and financial position.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.